New CEO at Fair-Med
This article was originally published in Scrip
Baar, Switzerland-based Fair-Med has named Oren Weininger chief executive officer. Prior to joining the privately owned firm, which aims to provide patients with quality generic medicines at affordable prices, Mr Weininger worked at Dexcel Pharma. He said, "I hope as CEO I will bring the company to international success with a quick expansion, based on my experience." Fair-Med is currently present in Europe, Australian and the MENA region.
You may also be interested in...
A steady flow of venture capital into the medical device industry continued in the first half of 2020 despite the novel coronavirus pandemic. While Biopharma companies secured more than $7.5bn in private financings between January and June.
Experts discuss the future of brain health, changing the stereotypical view of an Alzheimer’s patient and how technology and science have evolved the treatment possibilities for dementia patients in 2020 – even if ‘clinical practice is taking a long time to catch up.’
A complete response letter from the FDA in June knocked Intercept’s stock price down to 2014 levels, but perhaps the regulator is sending wider messages about NASH.